Navigation Links
Scientists uncover the potential to control adult stem cells
Date:4/10/2008

Research being presented today (10 April) at the UK National Stem Cell Network Annual Science Meeting in Edinburgh represents a step towards the use of Adult Stem Cells (ASCs) to repair damaged tissue. Speaking at the conference in Edinburgh, Professor Cay Kielty of the University of Manchester describes how she and her team have uncovered a messaging system that instructs ASCs to contribute to tissue repair in response to chemical signals in the body. This work, funded by the Medical Research Council, holds great hope for the development of techniques by which ASCs could be instructed to repair damaged tissues.

ASCs have potential for therapeutic use and avoid many of the ethical issues associated with embryonic stem cells. However, at present it is necessary to gain a better understanding of how, from first principles, ASCs can be controlled based on signalling systems that normally give instructions within the body. There is the potential in the future to apply such understanding to the generation of cells for transplant.

Professor Kieltys team study stem cells that are found in human bone marrow called mesenchymal stem cells (MSCs). MSCs have the ability to relocate and develop into several different types of cells and tissue and are very promising as a source of cells for transplant in tissue repair. As well as offering the potential for bespoke treatments derived from a persons own cells, MSCs are unlikely to trigger a severe immune response, and may be suitable for off-the-shelf treatments for tissue repair. This research focuses on the details of a messaging system that leads to the development of blood vessels from MSCs in the body. This system is called PDGF receptor signalling.

In PDGF receptor signalling, receptors on the surface of the MSCs receive messages in the form of molecules that are involved in directing human growth and development growth factors. It has been found that there is a complex messaging s
'/>"/>

Contact: Matt Goode
matt.goode@bbsrc.ac.uk
01-793-413-299
Biotechnology and Biological Sciences Research Council
Source:Eurekalert

Page: 1 2

Related biology news :

1. Scientists ask whether microscaffolding can help stem cells rebuild brain after stroke damage
2. Scientists find a fingerprint of evolution across the human genome
3. Death protein research secures funding for UCF scientists
4. Yale scientists visualize the machinery of mRNA splicing
5. Cold Spring Harbor Laboratory scientists devise potential approach to treat spinal muscular atrophy
6. Scientists discover 356 animal inclusions trapped in 100 million years old opaque amber
7. Great Ape Trust to gather internationally recognized scientists for Decade of the Mind III
8. CSHL scientists part of team that discovers role of rare gene mutations in schizophrenia
9. CSHL scientists identify a mechanism that helps fruit flies lock-in memories
10. Scientists find that squid beak is both hard and soft, a material that engineers want to copy
11. Scientists launch first comprehensive database of human oral microbiome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... the leading source of biometrics industry news, interviews and thought ... "When we launched FindBiometrics 12 years ago the industry ... and CEO of FindBiometrics. "Now it,s maturing very quickly. More ... on a very broad scale.  We are known for providing ...
(Date:1/22/2015)... MADISON, Wis. , Jan. 15, 2015  BellBrook ... for drug discovery, announced the launch of a ... of the company,s Transcreener UDP Assay, a high ... enzymes. The new assay will allow for sensitive ...
(Date:1/22/2015)... and POINT ROBERTS, Washington , January 20, ... leading sectors including technology and tech stocks, releases video from ... master pickpocket and security consultant Apollo Robbins . ... talks about the Wocket™ biometric smart wallet, a product of ...
Breaking Biology News(10 mins):Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 2Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 3
... Cell-based therapies have been shown to enhance ... produced only "modest results." In an effort to ... team from Germany has taken epithelial cells from ... them into mesenchymal cells. After transplanting the transitioned ...
... better at repelling attacks by mountain pine beetles, which have ... by the University of Colorado Boulder. The findings, published ... land managers make decisions about which trees to cull and ... against pine beetle infestation. The current mountain pine beetle ...
... the important transducers of noxious stimuli in the primary ... and hyperalgesia. However, there is no direct evidence that ... neuropeptide release from primary afferent neurons. A recent study ... Medicine in Japan demonstrated for the first time that ...
Cached Biology News:Transitioning epithelial cells to mesenchymal cells enhances cardiac protectivity 2Slippery bark protects trees from pine beetle attack, according to CU-Boulder study 2
(Date:3/3/2015)... 2015 Becht Engineering Co., Inc., ... has acquired The CECON Group, Inc., located in ... not announced. , Becht Engineering (http://www.becht.com ) ... including oil and gas production, refining, petrochemical, chemical, ... power sectors. The company has twelve offices in ...
(Date:3/3/2015)... DUBLIN , Mar. 03, 2015 Research ... announced the addition of Jain PharmaBiotech,s new report ... to their offering. , ... is to match the right drug to the ... design the appropriate treatment for a patient according ...
(Date:3/3/2015)... 2015  Johnson & Johnson Innovation LLC today announced ... (JLABS @SSF), a 30,000-square foot incubator located ... Francisco, Calif. The Johnson & Johnson Innovation, ... from across the healthcare spectrum including biotech, pharmaceutical, medical ... first resident startups have been selected, including the winners ...
(Date:3/3/2015)... ROCKVILLE, Md. , March 3, 2015  Synthetic Biologics, ... serious infections and diseases, with a focus on protecting the ... Officer, is scheduled to present at the 27th Annual ROTH ... Laguna Niguel in Dana ... on Tuesday, March 10, 2015 at 1:00 p.m. (Pacific Time). ...
Breaking Biology Technology:Global Personalized Medicine Market Report 2015 - Scientific and Commercial Aspects 2014-2024 2Global Personalized Medicine Market Report 2015 - Scientific and Commercial Aspects 2014-2024 3Johnson & Johnson Innovation Opens JLABS @South San Francisco and Announces First Five Resident Startups 2Johnson & Johnson Innovation Opens JLABS @South San Francisco and Announces First Five Resident Startups 3Johnson & Johnson Innovation Opens JLABS @South San Francisco and Announces First Five Resident Startups 4Johnson & Johnson Innovation Opens JLABS @South San Francisco and Announces First Five Resident Startups 5Synthetic Biologics to Present at the 27th Annual ROTH Conference 2
... Valeant,Pharmaceuticals International (NYSE: VRX ) ... to acquire Dow Pharmaceutical Sciences, Inc., a privately,held ... topical,products on a proprietary basis, as well as ... enhances Valeant,s,dermatology franchise in the United States through ...
... Resource enable researchers to quickly and effectively use this invaluable resource. ... ... OpenHelix today announced the availability of a new tutorial ... a public resource for the analysis of prokaryotes, including the complete ...
... Dec. 9 ev3 Inc. (Nasdaq: ... that it has received,510(k) clearance from the U.S. ... 0.035" and NanoCross 0.014" peripheral angioplasty balloon,catheters. ... EverCross and,NanoCross peripheral balloon catheters globally in January ...
Cached Biology Technology:Valeant to Acquire Dow Pharmaceutical Sciences, Inc. for $285 Million 2Valeant to Acquire Dow Pharmaceutical Sciences, Inc. for $285 Million 3Valeant to Acquire Dow Pharmaceutical Sciences, Inc. for $285 Million 4Valeant to Acquire Dow Pharmaceutical Sciences, Inc. for $285 Million 5New Online Tutorial for the Comprehensive Microbial Resource (CMR) 2ev3 Inc. Receives FDA Clearance to Market EverCross and NanoCross Peripheral Angioplasty Balloons 2ev3 Inc. Receives FDA Clearance to Market EverCross and NanoCross Peripheral Angioplasty Balloons 3